Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 79-82, January 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorsett, M. T.
Right arrow Articles by Gentry, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorsett, M. T.
Right arrow Articles by Gentry, G. A.

Inhibition of Rat Dihydropyrimidine Dehydrogenase by 5-Cyanouracil in Vitro1

Marion T. Dorsett2, Paul A. Morse, Jr. and Glenn A. Gentry

Department of Microbiology, University of Mississippi School of Medicine, Jackson, Mississippi, 39216

The aim of this work is the inhibition of pyrimidine catabolism in mammals, so that physiologically effective levels in circulating thymidine may be maintained. Dihydropyrimidine dehydrogenase was purified from rat and hamster livers, and various 5-substituted pyrimidines were tested as substrates. 5-Cyanouracil was reduced vigorously by enzyme from hamsters but only weakly by enzyme from rats; other analogs did not show this marked species difference. When 5-cyanouracil and uracil were tested together with the rat enzyme, the former blocked almost completely the reduction of uracil, which suggests that it is a good candidate for in vivo studies.

1 Supported by American Cancer Society grant T-357 and Faculty Research Associate Award PR-40 (P. A. M.), and USPHS training grant AI-69 and awards 5-K3-AI-7021 (G. A. G.) and 1-F1-GM-33650 (M. T. D.).

2 Submitted to the University of Mississippi in partial fulfillment of the requirements for the Doctor of Philosophy degree.

Received 5/16/68. Accepted 9/10/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.